Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Annexin A6 | 6 | 2022 | 17 | 3.430 |
Why?
|
| Breast Neoplasms | 10 | 2017 | 1679 | 1.060 |
Why?
|
| Calcium | 5 | 2022 | 487 | 1.020 |
Why?
|
| Receptors, Calcium-Sensing | 3 | 2017 | 13 | 0.990 |
Why?
|
| Cell Line, Tumor | 16 | 2022 | 2598 | 0.820 |
Why?
|
| Exosomes | 7 | 2018 | 124 | 0.750 |
Why?
|
| Hypercalcemia | 1 | 2022 | 13 | 0.750 |
Why?
|
| Calcium Channels | 2 | 2020 | 74 | 0.690 |
Why?
|
| ras Guanine Nucleotide Exchange Factors | 1 | 2020 | 3 | 0.660 |
Why?
|
| Cell Adhesion | 7 | 2020 | 237 | 0.630 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2020 | 222 | 0.590 |
Why?
|
| alpha-Defensins | 3 | 2025 | 22 | 0.530 |
Why?
|
| Signal Transduction | 9 | 2025 | 2111 | 0.520 |
Why?
|
| Blood Proteins | 3 | 2010 | 75 | 0.480 |
Why?
|
| Focal Adhesions | 2 | 2014 | 16 | 0.450 |
Why?
|
| Cell Proliferation | 8 | 2020 | 1420 | 0.440 |
Why?
|
| Protein Kinase C | 2 | 2004 | 124 | 0.420 |
Why?
|
| Quinazolines | 1 | 2013 | 37 | 0.420 |
Why?
|
| Humans | 34 | 2025 | 42163 | 0.400 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2019 | 933 | 0.400 |
Why?
|
| alpha-Fetoproteins | 2 | 2022 | 31 | 0.380 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2020 | 290 | 0.350 |
Why?
|
| Nuclear Proteins | 3 | 2018 | 330 | 0.330 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2025 | 101 | 0.330 |
Why?
|
| Carcinoma | 1 | 2010 | 106 | 0.320 |
Why?
|
| Cell Movement | 7 | 2020 | 640 | 0.310 |
Why?
|
| Onchocerca volvulus | 2 | 1997 | 5 | 0.280 |
Why?
|
| Female | 15 | 2023 | 24018 | 0.270 |
Why?
|
| Prognosis | 2 | 2020 | 850 | 0.270 |
Why?
|
| Parathyroid Glands | 3 | 2004 | 4 | 0.260 |
Why?
|
| Multiprotein Complexes | 1 | 2007 | 55 | 0.250 |
Why?
|
| Colitis, Ulcerative | 3 | 2025 | 68 | 0.250 |
Why?
|
| Parathyroid Hormone | 2 | 2004 | 40 | 0.240 |
Why?
|
| Colon | 3 | 2025 | 118 | 0.240 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2019 | 159 | 0.240 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 979 | 0.230 |
Why?
|
| Histones | 2 | 2018 | 194 | 0.230 |
Why?
|
| Carrier Proteins | 1 | 2007 | 318 | 0.220 |
Why?
|
| RNA, Small Interfering | 2 | 2025 | 436 | 0.220 |
Why?
|
| Colitis | 1 | 2025 | 69 | 0.210 |
Why?
|
| Enzyme Inhibitors | 2 | 2004 | 457 | 0.210 |
Why?
|
| Hypogonadism | 1 | 2023 | 23 | 0.200 |
Why?
|
| Animals | 14 | 2025 | 16695 | 0.200 |
Why?
|
| Hydroxyurea | 1 | 2023 | 34 | 0.200 |
Why?
|
| Antibodies, Monoclonal | 1 | 2025 | 301 | 0.200 |
Why?
|
| Crohn Disease | 2 | 2021 | 69 | 0.200 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 13 | 0.190 |
Why?
|
| Mentors | 1 | 2023 | 143 | 0.180 |
Why?
|
| Protein Precursors | 1 | 2002 | 59 | 0.180 |
Why?
|
| Multienzyme Complexes | 1 | 2002 | 69 | 0.180 |
Why?
|
| Neoplasm Proteins | 2 | 2022 | 228 | 0.180 |
Why?
|
| Acetylcysteine | 1 | 2002 | 57 | 0.180 |
Why?
|
| Receptors, Androgen | 1 | 2022 | 144 | 0.180 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 77 | 0.180 |
Why?
|
| Oxygen | 1 | 2022 | 217 | 0.180 |
Why?
|
| Enterotoxins | 1 | 2021 | 33 | 0.170 |
Why?
|
| Glucose | 1 | 2022 | 242 | 0.170 |
Why?
|
| Phosphorylation | 2 | 2019 | 973 | 0.170 |
Why?
|
| Organoids | 1 | 2021 | 33 | 0.170 |
Why?
|
| Cell Nucleus | 3 | 2018 | 383 | 0.170 |
Why?
|
| Cell Survival | 2 | 2019 | 934 | 0.160 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 64 | 0.160 |
Why?
|
| Ki-67 Antigen | 1 | 2020 | 34 | 0.160 |
Why?
|
| Mice | 6 | 2025 | 6490 | 0.160 |
Why?
|
| Transplantation, Heterologous | 1 | 2020 | 98 | 0.160 |
Why?
|
| Calcium Channel Blockers | 1 | 2020 | 57 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 4 | 2018 | 284 | 0.160 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 518 | 0.160 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 233 | 0.150 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 173 | 0.150 |
Why?
|
| Syndecan-4 | 1 | 2018 | 4 | 0.150 |
Why?
|
| Durapatite | 1 | 2018 | 18 | 0.150 |
Why?
|
| Cells, Cultured | 4 | 2021 | 1617 | 0.150 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 729 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 2 | 2010 | 189 | 0.140 |
Why?
|
| Luminescent Proteins | 1 | 2018 | 65 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2012 | 206 | 0.140 |
Why?
|
| Cell Membrane | 4 | 2018 | 400 | 0.140 |
Why?
|
| Age of Onset | 1 | 2017 | 115 | 0.130 |
Why?
|
| Retrospective Studies | 3 | 2021 | 2485 | 0.130 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 118 | 0.130 |
Why?
|
| Helminth Proteins | 1 | 1997 | 23 | 0.130 |
Why?
|
| Gene Frequency | 1 | 2017 | 203 | 0.130 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2018 | 89 | 0.130 |
Why?
|
| Astrocytoma | 1 | 2016 | 16 | 0.130 |
Why?
|
| Neoplasms | 3 | 2018 | 1341 | 0.130 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 928 | 0.130 |
Why?
|
| Amino Acids | 1 | 1997 | 150 | 0.130 |
Why?
|
| Brain Neoplasms | 1 | 2016 | 129 | 0.120 |
Why?
|
| Antigens, Helminth | 2 | 1997 | 34 | 0.110 |
Why?
|
| Cattle | 3 | 2013 | 505 | 0.110 |
Why?
|
| RNA Interference | 2 | 2018 | 246 | 0.110 |
Why?
|
| Protein Kinase C-epsilon | 2 | 2004 | 12 | 0.110 |
Why?
|
| Genotype | 1 | 2017 | 796 | 0.110 |
Why?
|
| Gene Expression | 2 | 2016 | 692 | 0.110 |
Why?
|
| Case-Control Studies | 1 | 2017 | 1266 | 0.110 |
Why?
|
| Down-Regulation | 2 | 2007 | 452 | 0.110 |
Why?
|
| Cell Line | 3 | 2014 | 1416 | 0.110 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 98 | 0.100 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 116 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2004 | 462 | 0.100 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 32 | 0.100 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 147 | 0.100 |
Why?
|
| Male | 7 | 2023 | 22779 | 0.100 |
Why?
|
| Lysosomes | 1 | 2013 | 88 | 0.100 |
Why?
|
| Chemotaxis | 1 | 2013 | 66 | 0.100 |
Why?
|
| Proteomics | 2 | 2021 | 363 | 0.100 |
Why?
|
| Head and Neck Neoplasms | 1 | 2013 | 81 | 0.100 |
Why?
|
| Nanoparticles | 1 | 2018 | 449 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 860 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 150 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2022 | 1068 | 0.100 |
Why?
|
| Cell Nucleus Shape | 1 | 2012 | 1 | 0.090 |
Why?
|
| Breast | 1 | 2013 | 139 | 0.090 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2013 | 187 | 0.090 |
Why?
|
| Onchocerca | 1 | 1990 | 5 | 0.080 |
Why?
|
| Glycerol | 1 | 2010 | 34 | 0.080 |
Why?
|
| Ions | 1 | 2010 | 71 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 744 | 0.080 |
Why?
|
| Hela Cells | 2 | 2012 | 370 | 0.080 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2010 | 69 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 207 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 214 | 0.080 |
Why?
|
| Endocytosis | 2 | 2020 | 117 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2009 | 160 | 0.070 |
Why?
|
| Contractile Proteins | 1 | 2007 | 7 | 0.070 |
Why?
|
| Replication Origin | 1 | 2007 | 15 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2010 | 548 | 0.070 |
Why?
|
| G1 Phase | 1 | 2007 | 33 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2009 | 230 | 0.060 |
Why?
|
| Time Factors | 2 | 2004 | 1848 | 0.060 |
Why?
|
| Sequence Analysis, Protein | 1 | 2007 | 51 | 0.060 |
Why?
|
| Microfilament Proteins | 1 | 2007 | 72 | 0.060 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 128 | 0.060 |
Why?
|
| DNA Helicases | 1 | 2007 | 46 | 0.060 |
Why?
|
| Amino Acid Sequence | 2 | 2007 | 1188 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 1559 | 0.060 |
Why?
|
| Gene Silencing | 1 | 2007 | 154 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2007 | 198 | 0.060 |
Why?
|
| Protein Transport | 1 | 2007 | 295 | 0.060 |
Why?
|
| Protein Binding | 2 | 2007 | 1076 | 0.060 |
Why?
|
| Chromatin | 1 | 2007 | 179 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 522 | 0.060 |
Why?
|
| Neomycin | 1 | 2004 | 5 | 0.060 |
Why?
|
| Maleimides | 1 | 2004 | 12 | 0.060 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2004 | 42 | 0.060 |
Why?
|
| Culture Media, Serum-Free | 1 | 2004 | 44 | 0.060 |
Why?
|
| Cations | 1 | 2004 | 49 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2007 | 239 | 0.060 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 79 | 0.060 |
Why?
|
| Protein Kinase C-alpha | 1 | 2004 | 9 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2004 | 181 | 0.050 |
Why?
|
| Carbazoles | 1 | 2004 | 46 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2004 | 139 | 0.050 |
Why?
|
| Laminin | 2 | 2014 | 58 | 0.050 |
Why?
|
| Proteoglycans | 2 | 2014 | 49 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 136 | 0.050 |
Why?
|
| Nucleoside-Phosphate Kinase | 1 | 2003 | 3 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 557 | 0.050 |
Why?
|
| Sperm Motility | 1 | 2023 | 45 | 0.050 |
Why?
|
| Indoles | 1 | 2004 | 178 | 0.050 |
Why?
|
| Plasminogen | 2 | 2013 | 10 | 0.050 |
Why?
|
| Fertility | 1 | 2023 | 63 | 0.050 |
Why?
|
| Semen | 1 | 2023 | 55 | 0.050 |
Why?
|
| Faculty | 1 | 2023 | 105 | 0.050 |
Why?
|
| Brefeldin A | 1 | 2002 | 4 | 0.050 |
Why?
|
| Disease Progression | 2 | 2018 | 661 | 0.050 |
Why?
|
| Middle Aged | 1 | 2017 | 11819 | 0.050 |
Why?
|
| Chloroquine | 1 | 2002 | 19 | 0.050 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2002 | 52 | 0.050 |
Why?
|
| Testis | 1 | 2023 | 203 | 0.050 |
Why?
|
| Spermatogenesis | 1 | 2023 | 160 | 0.050 |
Why?
|
| Calpain | 1 | 2002 | 35 | 0.050 |
Why?
|
| Kidney | 1 | 2004 | 363 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2002 | 64 | 0.050 |
Why?
|
| Peptides | 2 | 1997 | 357 | 0.040 |
Why?
|
| Mucin-6 | 1 | 2021 | 7 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2002 | 115 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2021 | 102 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2003 | 382 | 0.040 |
Why?
|
| Health Personnel | 1 | 2023 | 262 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2021 | 104 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2025 | 1066 | 0.040 |
Why?
|
| Mutation | 1 | 2004 | 1169 | 0.040 |
Why?
|
| Extracellular Space | 1 | 2018 | 36 | 0.040 |
Why?
|
| Nordefrin | 1 | 2018 | 1 | 0.040 |
Why?
|
| Leupeptins | 1 | 2018 | 12 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2018 | 26 | 0.040 |
Why?
|
| Pancreas | 1 | 2018 | 45 | 0.040 |
Why?
|
| Half-Life | 1 | 2018 | 63 | 0.040 |
Why?
|
| Heme Oxygenase-1 | 1 | 2018 | 52 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2018 | 36 | 0.040 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2018 | 60 | 0.040 |
Why?
|
| Protein Stability | 1 | 2018 | 47 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 62 | 0.040 |
Why?
|
| Sulfur Radioisotopes | 1 | 1997 | 7 | 0.040 |
Why?
|
| Autoradiography | 1 | 1997 | 35 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 1997 | 51 | 0.030 |
Why?
|
| Electrophoresis | 1 | 1997 | 24 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 223 | 0.030 |
Why?
|
| Methionine | 1 | 1997 | 27 | 0.030 |
Why?
|
| Logistic Models | 1 | 2021 | 1001 | 0.030 |
Why?
|
| Culture Media | 1 | 1997 | 96 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2021 | 426 | 0.030 |
Why?
|
| Hydroxylation | 1 | 1997 | 12 | 0.030 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2017 | 21 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2018 | 254 | 0.030 |
Why?
|
| Students | 1 | 2023 | 617 | 0.030 |
Why?
|
| Muramidase | 1 | 2017 | 31 | 0.030 |
Why?
|
| Light | 1 | 2018 | 182 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2018 | 293 | 0.030 |
Why?
|
| Ligands | 1 | 2018 | 387 | 0.030 |
Why?
|
| Biopsy | 1 | 2017 | 176 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 236 | 0.030 |
Why?
|
| Intestinal Mucosa | 1 | 2017 | 131 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 188 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 403 | 0.030 |
Why?
|
| Polysaccharide-Lyases | 1 | 2014 | 10 | 0.030 |
Why?
|
| Heparitin Sulfate | 1 | 2014 | 23 | 0.030 |
Why?
|
| Heparin | 1 | 2014 | 39 | 0.030 |
Why?
|
| Fibronectins | 1 | 2014 | 69 | 0.030 |
Why?
|
| Cytoplasm | 1 | 2014 | 154 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2013 | 107 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 683 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2013 | 95 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2013 | 102 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 97 | 0.020 |
Why?
|
| Collagen | 1 | 2013 | 178 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2013 | 106 | 0.020 |
Why?
|
| Replication Protein A | 1 | 2012 | 8 | 0.020 |
Why?
|
| Annexins | 1 | 2011 | 6 | 0.020 |
Why?
|
| Fluorescence Recovery After Photobleaching | 1 | 2011 | 9 | 0.020 |
Why?
|
| Centrosome | 1 | 2012 | 30 | 0.020 |
Why?
|
| beta-Cyclodextrins | 1 | 2011 | 35 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2013 | 223 | 0.020 |
Why?
|
| Biological Transport | 1 | 2011 | 201 | 0.020 |
Why?
|
| DNA Replication | 1 | 2012 | 153 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 1554 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2010 | 10 | 0.020 |
Why?
|
| Onchocerciasis | 1 | 1990 | 7 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1990 | 39 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 1990 | 50 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1990 | 168 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 411 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2012 | 348 | 0.020 |
Why?
|
| Glycoproteins | 1 | 1990 | 127 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 884 | 0.020 |
Why?
|
| Skin | 1 | 1990 | 185 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 711 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 7982 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 658 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2010 | 1010 | 0.020 |
Why?
|
| Crystallization | 1 | 2007 | 88 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2007 | 195 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 502 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 295 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 318 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2007 | 285 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2007 | 420 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 1804 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 997 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2007 | 461 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2003 | 51 | 0.010 |
Why?
|
| Surface Plasmon Resonance | 1 | 2003 | 35 | 0.010 |
Why?
|
| Point Mutation | 1 | 2003 | 98 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 271 | 0.010 |
Why?
|
| Protein Folding | 1 | 2003 | 123 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 427 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2003 | 199 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 670 | 0.010 |
Why?
|